Advisory Board

The Duke-Margolis Center is overseen by Provost Sally Kornbluth and Chancellor of Health Affairs Eugene Washington, who also serve on the Center’s External Advisory Board, chaired by Dr. Robert Margolis.

Approximately fifteen senior advisors serve on the advisory board, bringing experience from policy-relevant public and private sectors including healthcare payers, legislative, biomedical, foundation, and high technology. The Board’s advisory function will be served predominantly through participation in bi-annual face-to-face meetings, alternating between the Washington, DC and Durham, NC locations, but advisors may also provide occasional advice for particular initiatives.

Current members are:

Drew Altman, PhD
President and Chief Executive Officer, Henry J. Kaiser Family Foundation

David Brailer, MD, PhD
Managing Partner, Health Evolution

Tony Coles, MD, MPH (M’86)
Founding Investor, Chairman and Chief Executive Officer, Yumanity Therapeutics

Susan Dentzer
President and CEO, Network for Excellence in Health Innovation (NEHI)

Susan DeVore
President and Chief Executive Officer, Premier, Inc.

David Feinberg, MD, MBA
President & Chief Executive Officer, Geisinger Health

Joseph Jimenez
Chief Executive Officer, Novartis

Jessica Mega, MD, MPH
Chief Medical Officer, Verily (formerly Google Life Sciences)

David P. King, JD
Chairman and Chief Executive Officer, Laboratory Corporation of America

Governor Michael O. Leavitt
Leavitt Partners

Dan Mendelson, MPP
President, Avalere Health

Debra L. Ness, MS
President, National Partnership for Women & Families

Peter Orszag, PhD
Vice Chairman of Investment Banking & Global Co-Head of Healthcare, Lazard

Joseph R. Swedish, MHA (G ’79)
Chairman, President, and Chief Executive Officer, Anthem Healthcare